SEARCH

SEARCH BY CITATION

References

  • Alessandrini A., Namura S., Moskowitz M. A. and Bonventre J. V. (1999) MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc. Natl Acad. Sci. USA 96, 1286612869.
  • Aruffo A., Stamenkovic I., Melnick M., Underhill C. B. and Seed B. (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61, 13031313.
  • Barone F. C., Hillegass L. M., Price W. J., White R. F., Lee E. V., Feuerstein G. Z., Sarau H. M., Clark R. K. and Griswold D. E. (1991) Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J. Neurosci. Res. 29, 336345.
  • Barone F. C., Irving E. A., Ray A. M., Lee J. C., Kassis S., Kumar S., Badger A. M., White R. F., McVey M. J., Legos J. J., Erhardt J. A., Nelson A. H., Ohlstein E. H., Hunter A. J., Ward K., Smith B. R., Adams J. L. and Parsons A. A. (2001) SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J. Pharmacol. Exp. Ther. 296, 312321.
  • Cuff C. A., Kothapalli D., Azonobi I., Chun S., Zhang Y., Belkin R., Yeh C., Secreto A., Assoian R. K., Rader D. J. and Puré E. (2001) The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J. Clin. Invest. 108, 10311040.
  • Dutka A. J., Kochanek P. M. and Hallenbeck J. M. (1989) Influence of graulocytopenia on canine cerebral ischemia induced by an embolism. Stroke 20, 390395.
  • Foster L. C., Wiesel P., Huggins G. S., Panares R., Chin M. T., Pellacani A. and Perrella M. A. (2000) Role of activating protein-1 and high mobility group-I (Y) protein in the induction of CD44 gene expression by interleukin-1beta in vascular smooth muscle cells. FASEB J. 14, 368378.
  • Garcia J. H. and Kamijyo Y. (1974) Cerebral infarction: evolution of histopathological changes after occlusion of a middle cerebral artery in primates. J. Neuropathol. Exp. Neurol. 33, 409421.
  • Hallenbeck J. M., Dutka A. J., Tanishima T., Kochanek P. M., Kumaroo K. K., Thompson C. B., Obrenovitch T. P. and Contreras T. J. (1986) Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early postischemic period. Stroke 17, 246253.
  • Lesley J., Hyman R. and Kincade P. W. (1993) CD44 and its interaction with extracellular matrix. Adv. Immunol. 54, 271335.
  • Loddick S. A. and Rothwell N. J. (1996) Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J. Cereb. Blood Flow Metab. 16, 932940.
  • Maiti A., Maki G. and Johnson P. (1998) TNF-alpha induction of CD44-mediated leukocyte adhesion by sulfation. Science 282, 941943.
  • Matsuo Y., Onodera H., Shiga Y., Nakamura M., Ninomiya M., Kihara T. and Kogure K. (1994) Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 25, 14691475.
  • Mikecz K., Dennis K., Shi M. and Kim J. H. (1999) Modulation of hyaluronan receptor (CD44) function in vivo in a murine model of rheumatoid arthritis. Arthritis Rheum. 42, 659668.
  • Puré E. and Cuff C. A. (2001) A crucial role for CD44 in inflammation. Trends Mol. Med. 7, 213221.
  • Rothwell N. J. and Luheshi G. N. (2000) Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23, 618625.
  • Schmits R., Filmus J., Gerwin N., Senaldi G., Kiefer F., Kundig T., Wakeham A., Shahinian A., Catzavelos C., Rak J., Furlonger C., Zakarian A., Simard J. J., Ohashi P. S., Paige C. J., Gutierrez-Ramos J. C. and Mak T. W. (1997) CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 90, 22172233.
  • Teder P., Vandivier R. W., Jiang D., Liang J., Cohn L., Pure E., Henson P. M. and Noble P. W. (2002) Resolution of lung inflammation by CD44. Science 296, 155158.
  • Wang X. K. and Feuerstein G. Z. (2000) Role of immune and inflammatory mediators in CNS injury. Drug News Perspect. 13, 133140.
  • Wang H., Zhan Y., Xu L., Feuerstein G. Z. and Wang X. (2001) Use of suppression subtractive hybridization for differential gene expression in stroke: discovery of CD44 gene expression and localization in permanent focal stroke in rats. Stroke 32, 10201027.
  • Wang X. K., Xu L., Wang H., Grzanna R., Zhan Y., Knabb R. M., Luettgen J. M., Bozarth T. A., Galemmo R. A., Wong P. C., Bernard R., Vargas H., Chopp M., Friedman S. M. and Feuerstein G. Z. (2002) Inhibition of factor Xa reduces ischemic brain damage following thrombo-embolic stroke in rats. Stroke in press.
  • Wittig B., Seiter S., Schmidt D. S., Zuber M., Neurath M. and Zoller M. (1999) CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases. Lab. Invest. 79, 747759.
  • Zhang R. L., Chopp M., Li Y., Zaloga C., Jiang N., Jones M. L., Miyasaka M. and Ward P. A. (1994) Anti-ICAM-1 antibody reduces ischemic cell damage after transient middle cerebral artery occlusion in the rat. Neurology 44, 17471751.
  • Del Zoppo G., Ginis I., Hallenbeck J. M., Iadecola C., Wang X. and Feuerstein G. Z. (2000) Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol. 10, 95112.